Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Progyny Sees Q4 2025 Adj EPS $0.37-$0.40 vs $0.14 Est; Sees Sales $292.700M-$307.700M vs $302.589M Est

Author: Benzinga Newsdesk | November 06, 2025 04:14pm

Fourth Quarter of 2025 Outlook:
- Revenue is projected to be $292.7 million to $307.7 million, reflecting a change of (1.9)% to 3.1%; excluding the $35.9 million of revenue in 2024 from the large client who was under a transition agreement in the first half of 2025, revenue is expected to increase by 11.5% to 17.2%
- Net income is projected to be $12.5 million to $15.5 million, or $0.14 to $0.17 per diluted share, on the basis of approximately 91 million assumed weighted-average fully diluted-shares outstanding
- Adjusted EBITDA1 is projected to be $45.3 million to $49.3 million
- Adjusted earnings per diluted share1 is projected to be $0.37 to $0.40

Posted In: PGNY